Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways

Fig. 7

The outcome of DA (5 µM) and BMS-202 (5 µM) on colony formation of (a) SKBR3 and (b) ZR75 cell lines in soft agar after 21 days. DA and BMS-202 inhibit colony formation of SKBR3 and ZR75 in comparison with their matched control cells. Colonies were counted manually and expressed as a percentage of treatment relative to the control (Mean ± SEM)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us